Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06853990 · ClinicalTrials.gov registry record · NA

Innovative Automated Insulin Delivery System for Type 2 Diabetes

A NA study of Type 2 Diabetes and Insulin Treated Type 2 Diabetes Mellitus, sponsored by Deka Research and Development.

Active
Registry status
NA
Development phase
300
Enrollment target
20
Study locations

NCT06853990: Active NA study of Type 2 Diabetes and Insulin Treated Type 2 Diabetes Mellitus, sponsored by Deka Research and Development.

NCT06853990 is a NA study of Type 2 Diabetes and Insulin Treated Type 2 Diabetes Mellitus that is active but no longer recruiting, run by Deka Research and Development. The registered enrollment target is 300 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (92% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06853990, a NA study of Type 2 Diabetes and Insulin Treated Type 2 Diabetes Mellitus, is active but no longer recruiting, sponsored by Deka Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
20
Study locations

Study Summary

The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes.

Primary Outcome

HbA1c will be tested first for non-inferiority (non-inferiority limit 0.3%) and then if non-inferiority is demonstrated, it will be tested for superiority.

Conditions Studied

Type 2 Diabetes Insulin Treated Type 2 Diabetes Mellitus

Interventions

  • DEVICE twiist insulin delivery system

Study Locations (20)

California

  • Scripps Whittier Diabetes Institute - La Jolla
  • Hoag Memorial Hospital Presbyterian - Newport Beach
  • Sansum Diabetes Research Institute - Santa Barbara

Massachusetts

  • Massachusetts General Hospital - Boston
  • Boston Medical Center - Boston
  • Joslin Diabetes Center - Boston

Georgia

  • Emory University - Atlanta
  • Endocrine Research Solutions, Inc - Roswell

Michigan

  • University of Michigan - Ann Arbor
  • Henry Ford Health - Detroit

Minnesota

  • International Diabetes Center - Health Partners Institute - Minneapolis
  • Mayo Clinic - Rochester

Colorado

  • University of Colorado - Aurora

Florida

  • University of Miami - Miami

Idaho

  • Rocky Mountain Clinical Research, LLC - Idaho Falls

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-04-14
Est. Completion 2026-06
Phase NA
Deka Research and Development

4 total trials

What the registry record for NCT06853990 still lists

NCT06853990 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which twiist insulin delivery system is the first listed.

NCT06853990 names 20 study sites across 13 states, led by California, Massachusetts, Georgia.

Frequently Asked Questions

What is clinical trial NCT06853990 about?

NCT06853990 is a clinical study titled "Innovative Automated Insulin Delivery System for Type 2 Diabetes". The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes.

What is the current status of trial NCT06853990?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-04-14. Estimated completion is 2026-06.

What conditions does trial NCT06853990 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Insulin Treated Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT06853990?

The interventions under investigation include: twiist insulin delivery system (DEVICE).

Who is sponsoring clinical trial NCT06853990?

This trial is sponsored by Deka Research and Development, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06853990 being conducted?

This trial has 20 study locations across California, Colorado, Florida, Georgia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06853990's enrollment target sits among peer trials

300 67th of 327 higher than 257 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06853990, the US trial registry maintained by the National Library of Medicine. NCT06853990 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.